002938:SZSEAvary Holding (Shenzhen) Co., Ltd. Class A Analysis
Data as of 2026-06-10 - not real-time
CN¥111.06
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock trades at 111.06, sitting just above the computed 20‑day SMA and well within the 81.5 support zone, while the 30‑day volatility of ~77% signals a highly choppy price action.
Technical gauges show the RSI at 62 (overbought) and a bearish MACD histogram, suggesting short‑term downside pressure despite the bullish SMA crossover.
Fundamentally, the PE of 69× dwarfs the industry average of 36, margins are thin (gross 22%, operating 8%), revenue is contracting and free cash flow is negative, all pointing to a value‑oriented, potentially overvalued profile.
Dividend sustainability is questionable given the modest 0.87% yield, a payout of 62.5% and negative free cash flow, implying the dividend may not be reliably maintained.
Technical gauges show the RSI at 62 (overbought) and a bearish MACD histogram, suggesting short‑term downside pressure despite the bullish SMA crossover.
Fundamentally, the PE of 69× dwarfs the industry average of 36, margins are thin (gross 22%, operating 8%), revenue is contracting and free cash flow is negative, all pointing to a value‑oriented, potentially overvalued profile.
Dividend sustainability is questionable given the modest 0.87% yield, a payout of 62.5% and negative free cash flow, implying the dividend may not be reliably maintained.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- overbought RSI indicating near‑term price weakness
- bearish MACD histogram suggesting momentum shift
- proximity to support level at 81.5 limiting downside
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- bullish SMA crossover reflecting underlying trend
- sector demand for electronic components sustaining revenue
- high PE relative to industry indicating valuation pressure
Long Term
> 3 yearsCautious
Model confidence: 3/10
Key Factors
- persistent overvaluation (PE ~69) versus peers
- negative free cash flow and high debt‑to‑equity ratio
- questionable dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-1.20%
Profit Margin9.51%
P/E Ratio69.4
ROE10.78%
ROA5.26%
Debt/Equity18.11
P/B Ratio7.4
Op. Cash FlowCN¥7.9B
Free Cash FlowCN¥-2740767488
Industry P/E36.0
Technical Analysis
TrendBullish
RSI62.4
SupportCN¥81.51
ResistanceCN¥122.97
MA 20CN¥103.43
MA 50CN¥80.47
MA 200CN¥59.76
MACDBearish
VolumeIncreasing
Fear & Greed Index83.77
Valuation
Fair ValueCN¥34.18
Target PriceCN¥70.42
Upside/Downside-36.59%
GradeOvervalued
TypeValue
Dividend Yield0.87%
Risk Assessment
Beta0.06
Volatility76.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.